SPAZZOLINI, CARLA
 Distribuzione geografica
Continente #
NA - Nord America 325
EU - Europa 202
AS - Asia 194
Continente sconosciuto - Info sul continente non disponibili 1
Totale 722
Nazione #
US - Stati Uniti d'America 319
CN - Cina 188
IE - Irlanda 105
FI - Finlandia 39
DE - Germania 24
UA - Ucraina 19
IT - Italia 7
CA - Canada 6
FR - Francia 3
JP - Giappone 3
GB - Regno Unito 2
SE - Svezia 2
BE - Belgio 1
EU - Europa 1
IN - India 1
IR - Iran 1
SG - Singapore 1
Totale 722
Città #
Dublin 105
Chandler 91
Nanjing 48
Jacksonville 40
Beijing 36
Ashburn 35
Nanchang 20
Wilmington 19
Changsha 18
Helsinki 18
Princeton 18
Lawrence 16
Shenyang 15
Shanghai 13
Jiaxing 12
Medford 11
Hangzhou 8
Hebei 6
Tianjin 6
Toronto 6
Los Angeles 4
Falls Church 3
Norwalk 3
Ann Arbor 2
Boardman 2
Chicago 2
Milan 2
New York 2
Orange 2
Pavia 2
San Francisco 2
Seattle 2
Tokyo 2
Zhengzhou 2
Borås 1
Brussels 1
Des Moines 1
Fairfield 1
Jinan 1
Kavir 1
Kunming 1
Milton Keynes 1
Nuremberg 1
Pune 1
San Genesio Ed Uniti 1
Simi Valley 1
Singapore 1
Verona 1
Walnut 1
Totale 588
Nome #
Risk stratification in the Long-QT Syndrome 71
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 64
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 56
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 55
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 52
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 49
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 46
Response by Crotti et al to Letter Regarding Article, "Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3' Untranslated Region of KCNQ1?" 43
The genetics underlying acquired long QT syndrome: impact for genetic screening. 43
Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease. 41
Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists. 40
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 39
Cost-effectiveness of neonatal ECG screening for the long QT syndrome 38
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 38
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 37
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome. 37
Totale 749
Categoria #
all - tutte 3.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.050


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020193 58 80 0 3 0 5 0 6 0 17 24 0
2020/202140 6 3 0 3 0 4 0 13 1 7 3 0
2021/202264 0 0 6 0 2 2 0 6 1 0 11 36
2022/2023262 38 20 11 10 19 22 0 14 119 2 6 1
2023/2024102 8 23 2 7 8 18 3 15 2 7 1 8
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 749